Rocket Lab Forecast, price target & analysts
Why the stock moved Beta
Rocket Lab Target price 2026 - Analyst rating & recommendation
Rocket Lab Classifications & Recommendation
Rocket Lab Price Target
| Target Price | $107.10 |
| Price | $54.73 |
| Potential | 95.69% |
| Number of Estimates | 25 |
| 25 Analysts have issued a price target Rocket Lab 2027 . The average Rocket Lab target price is $107.10. This is 95.69% higher than the current stock price. The highest price target is $138.60 153.24% , the lowest is $64.64 18.11% . | |
| A rating was issued by 26 analysts: 21 Analysts recommend Rocket Lab to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Rocket Lab stock has an average upside potential 2027 of 95.69% . Most analysts recommend the Rocket Lab stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
28 Analysts have issued a sales forecast Rocket Lab 2026 . The average Rocket Lab sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
22 Analysts have issued an Rocket Lab EBITDA forecast 2026. The average Rocket Lab EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
27 Rocket Lab Analysts have issued a net profit forecast 2026. The average Rocket Lab net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Current Rocket Lab Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citizens |
Market Outperform
➜
Market Outperform
|
Unchanged | Oct 16 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Oct 15 2026 |
| Keybanc |
Overweight
➜
Overweight
|
Unchanged | Oct 15 2026 |
| TD Cowen |
Buy
➜
Buy
|
Unchanged | Oct 15 2026 |
| TD Cowen |
Buy
➜
Buy
|
Unchanged | Oct 09 2026 |
| Barclays |
➜
Overweight
|
Initiated | Oct 09 2026 |
| Citigroup |
➜
Buy
|
Initiated | Oct 01 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Citizens:
Market Outperform
➜
Market Outperform
|
Oct 16 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Oct 15 2026 |
|
Unchanged
Keybanc:
Overweight
➜
Overweight
|
Oct 15 2026 |
|
Unchanged
TD Cowen:
Buy
➜
Buy
|
Oct 15 2026 |
|
Unchanged
TD Cowen:
Buy
➜
Buy
|
Oct 09 2026 |
|
Initiated
Barclays:
➜
Overweight
|
Oct 09 2026 |
|
Initiated
Citigroup:
➜
Buy
|
Oct 01 2026 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
